You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice
About Guidelines Email Guidelines Team

Management of Early-Stage Hodgkin Lymphoma

Version: 2 ID: GL 6-20 May 2023
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
J. Herst, M. Crump, F. Baldassarre, J. MacEachern, J. Sussman, D. Hodgson, M. Cheung , Hematology Disease Site Group

Guideline Objective

To make recommendations on management strategies for patients with early-stage Hodgkin Lymphoma (HL).

Patient Population

Patients with early-stage Hodgkin Lymphoma.

Intended Guideline Users

Clinicians involved in the management of patients with early-stage Hodgkin Lymphoma, including radiation oncologists and clinical hematologists/oncologists.

Research Question(s)

  1. What are the optimum radiation dose and schedule and what are the best chemotherapy regimens for the treatment of patients with early-stage Hodgkin lymphoma (HL)?
  2. What are the best strategies for the prevention of early and late adverse events in patients with early-stage HL?
  3. What is the role of PET in guiding therapeutic decisions in the management of early stage HL?
  4. What are the best strategies for the treatment of subgroups of patients with early stage HL, such as those with very favourable or unfavourable disease?
pdf download Summary (PDF) (190.26 KB)
pdf download Full Report (PDF) (1.93 MB)